Allo-HLA reactivity of virus-specific memory T cells is common.
about
How to select the best available related or unrelated donor of hematopoietic stem cells?Cross-Reactivity of TCR Repertoire: Current Concepts, Challenges, and Implication for AllotransplantationAlloantibody Generation and Effector Function Following Sensitization to Human Leukocyte AntigenMemory T Cell MigrationCo-Stimulatory Blockade of the CD28/CD80-86/CTLA-4 Balance in Transplantation: Impact on Memory T Cells?Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney TransplantationDrug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoireFever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.Allorecognition by T Lymphocytes and Allograft RejectionRecent Developments in Cellular Immunotherapy for HSCT-Associated ComplicationsAbacavir-reactive memory T cells are present in drug naïve individualsPredicting alloreactivity in transplantation.Pathogen Stimulation History Impacts Donor-Specific CD8(+) T Cell Susceptibility to Costimulation/Integrin Blockade-Based TherapyAllogeneic major histocompatibility complex-mismatched equine bone marrow-derived mesenchymal stem cells are targeted for death by cytotoxic anti-major histocompatibility complex antibodiesCross-reactivity of herpesvirus-specific CD8 T cell lines toward allogeneic class I MHC molecules.Candida-elicited murine Th17 cells express high Ctla-4 compared with Th1 cells and are resistant to costimulation blockadeMixed T cell receptor dimers harbor potentially harmful neoreactivity.High-throughput identification of potential minor histocompatibility antigens by MHC tetramer-based screening: feasibility and limitations.High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belataceptTransplantation tolerance: from theory to clinic.Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjectsEffective elicitation of human effector CD8+ T Cells in HLA-B*51:01 transgenic humanized mice after infection with HIV-1.The allo- and viral-specific immunosuppressive effect of belatacept, but not tacrolimus, attenuates with progressive T cell maturationDefining the alloreactive T cell repertoire using high-throughput sequencing of mixed lymphocyte reaction cultureHLA-E-restricted cross-recognition of allogeneic endothelial cells by CMV-associated CD8 T cells: a potential risk factor following transplantation.PD-L1 blockade effectively restores strong graft-versus-leukemia effects without graft-versus-host disease after delayed adoptive transfer of T-cell receptor gene-engineered allogeneic CD8+ T cells.Cross-reactive anti-viral T cells increase prior to an episode of viral reactivation post human lung transplantation.T cell-mediated hypersensitivity reactions to drugsAlloreactivity across HLA barriers is mediated by both naïve and antigen-experienced T cells.Combination of C-X-C motif chemokine 9 and C-X-C motif chemokine 10 antibodies with FTY720 prolongs the survival of cardiac retransplantation allografts in a mouse model.Graft versus leukemia response without graft-versus-host disease elicited by adoptively transferred multivirus-specific T-cells.Microbiota—implications for immunity and transplantation.Identification of a naturally processed HLA-Cw7-binding peptide that cross-reacts with HLA-A24-restricted ovarian cancer-specific CTLs.The Microbiome, Systemic Immune Function, and Allotransplantation.Heterogeneity within T Cell Memory: Implications for Transplant ToleranceA foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR.Overcoming the memory barrier in tolerance induction: molecular mimicry and functional heterogeneity among pathogen-specific T-cell populations.Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8(+) memory T cells.Enhancing alloreactivity does not restore GVHD induction but augments skin graft rejection by CD4⁺ effector memory T cells
P2860
Q26744109-474E609A-F97A-4967-BB9F-20ACF63A38ABQ26752289-BD292E31-6A01-437C-A858-6950E04F9653Q26766411-5AB44FD1-EE20-4509-89DD-7625412083FEQ26781515-0BDFD50A-6152-4266-B339-B628EEE98A42Q26796099-76AAD72F-6082-4DF3-BF16-3EDD58B728BCQ26800980-7ACBF6B6-CBA2-4F91-856C-3BFA63522588Q26863724-7B9B37FA-DDD1-4023-ACF9-E18216B1EBACQ27679355-82913D6E-C25A-49B6-A1A3-8F8E0822364CQ27692095-2AE67E3B-1BEC-4EEC-9C4A-3EDCC618EBA9Q28067365-8831A0B5-24C5-43F6-8A92-53F262D87DC5Q28079823-4128B41B-4432-4512-8C80-6314ECF9BB36Q28543405-D4217786-CD85-4EB5-9973-DBF0E8735EA4Q33608371-A0E843A5-AEB2-41E9-8B2A-62F8C3B81650Q33636211-2FAA905F-9F12-4B12-9F32-A84136A1A4E9Q33658311-3A134C90-855E-4977-97AC-AB9375877042Q33658817-4E5001E3-7132-4E28-8755-E5B66A96BEF8Q33809102-8EE8A3C9-CCF6-47FD-9E7D-5AE225A92258Q33934631-BCD251C3-CF9C-4BB2-82B1-30F4F3941AA4Q33995557-A49201B3-2ECE-4D12-AFF0-5A01200D24E8Q34014967-D3F9E42B-D218-4880-9418-2C5B49A7E475Q34082059-850B6D0C-D91B-4655-A73C-ABFBD3376E4DQ34374139-AC36C27A-4EDC-4576-9477-2E03D580159AQ34374708-27E59666-EED2-4563-87E8-C331D359C543Q34400561-115CA3F4-9D91-4A29-8A39-BDAC9F16C778Q34446000-F1C5F98D-B992-44CE-BD2B-0C29843C87B4Q34506165-E1A6AB7A-8555-4AC3-B963-C035C4DFFD49Q34557896-DF56F65E-2135-491E-B84A-4A539BB6EC1FQ34584683-76AB4709-E913-44D3-8BE3-1707B64C8C30Q34971993-EEAEAC81-F57A-487D-902C-703F4F8AB78EQ35000627-06F17F23-BF06-44C4-907F-802C5ACF980DQ35048674-1CB3C91A-4011-4960-B4C0-BF9E3F51FD5BQ35591430-9C68F626-6594-481F-9207-A09BC6A0699DQ35627459-15F054F4-4BCD-4743-851E-ED66231C6796Q35717863-4A9D3377-4A2D-4ECC-97C7-6B7B64CAA4AFQ35866187-51C8D81C-8792-4069-A35A-8DB0A2D87368Q35927610-E1D21BE9-8E5B-43E1-9618-E17BA36ED6F7Q36057568-864FABC8-56EB-4104-83B0-53FC5AF993D3Q36273291-BC352BEC-0FF6-4A79-9213-DBDA05FA1D0BQ36305532-47FCE1E2-78E1-48A0-970B-C39DF6F660A0Q36453025-5597BFCB-5644-445A-A161-4667CA6DD48E
P2860
Allo-HLA reactivity of virus-specific memory T cells is common.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Allo-HLA reactivity of virus-specific memory T cells is common.
@en
Allo-HLA reactivity of virus-specific memory T cells is common.
@nl
type
label
Allo-HLA reactivity of virus-specific memory T cells is common.
@en
Allo-HLA reactivity of virus-specific memory T cells is common.
@nl
prefLabel
Allo-HLA reactivity of virus-specific memory T cells is common.
@en
Allo-HLA reactivity of virus-specific memory T cells is common.
@nl
P2093
P1433
P1476
Allo-HLA reactivity of virus-specific memory T cells is common.
@en
P2093
Avital L Amir
Dave L Roelen
Frans H J Claas
Ilias I N Doxiadis
J H Frederik Falkenburg
Lloyd J A D'Orsogna
Marleen M van Loenen
Menno A W G van der Hoorn
Michel G D Kester
Mirjam H M Heemskerk
P304
P356
10.1182/BLOOD-2009-07-234906
P407
P577
2010-02-16T00:00:00Z